IT'S NOT S. BOVIS AS YOU THINK: CLOSTRIDIUM SEPTICUM BACTEREMIA AND ENDOCARDITIS ASSOCIATED WITH METASTATIC COLORECTAL CANCER

被引：0
|
作者：
Dy, Paul Stendahl
Paz, Micaela Kristina
Sridhar, Sushrutha
Yalamanchili, Shashi
机构：
来源：
CHEST | 2023年 / 164卷 / 04期
关键词：
D O I：
10.1016/j.chest.2023.07.1685
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：2529A / 2529A
页数：1
相关论文
共 50 条
  • [31] Erratum: The LAUsanne STAPHylococcus aureus ENdocarditis (LAUSTAPHEN) score: A prediction score to estimate initial risk for infective endocarditis in patients with S. aureus bacteremia (vol 9, 961579, 2022)
    Papadimitriou-Olivgeris, M.
    Monney, P.
    Mueller, L.
    Senn, L.
    Guery, B.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [32] Professor Hope S. Rugo: Reversing resistance and hormone therapy for metastatic breast cancer
    Rugo, Hope S.
    CHINESE CLINICAL ONCOLOGY, 2014, 3 (04)
  • [33] A controlled-release oral opioid supports S. aureus survival in injection drug preparation equipment and may increase bacteremia and endocarditis risk
    Kasper, Katherine J.
    Manoharan, Iswarya
    Hallam, Brian
    Coleman, Charlotte E.
    Koivu, Sharon L.
    Weir, Matthew A.
    Mccormick, John K.
    Silverman, Michael S.
    PLOS ONE, 2019, 14 (08):
  • [34] Phase II study with oxaliplatin and S-1 for patients with metastatic colorectal cancer
    Zang, D. Y.
    Lee, B. H.
    Park, H. -C.
    Song, H. H.
    Kim, H. J.
    Jung, J. Y.
    Kim, J. H.
    Kim, H. Y.
    Kwon, J. H.
    Hwang, S. W.
    Park, S. R.
    Park, C. H.
    Kim, K. O.
    Kim, M. -J.
    Jang, K. M.
    ANNALS OF ONCOLOGY, 2009, 20 (05) : 892 - 896
  • [35] S-1 is a cost-effective alternative to capecitabine in metastatic colorectal cancer
    van Oijen, M.
    Kwakman, R.
    Punt, C.
    ANNALS OF ONCOLOGY, 2020, 31 : S224 - S224
  • [36] Bevacizumab plus S-1 and raltitrexed for refractory metastatic colorectal cancer.
    Chen, Ye
    Liu, Jiyan
    Gou, Hongfeng
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [37] The pathologist's involvement in anti-EGFR antibody therapy in metastatic colorectal cancer
    Sacoun, Esther
    ANNALES DE PATHOLOGIE, 2010, 30 (04) : VII - X
  • [38] Understanding the mechanisms of action of antiangiogenic agents in metastatic colorectal cancer: A clinician's perspective
    Clarke, J. M.
    Hurwitz, H. I.
    Rangwala, F.
    CANCER TREATMENT REVIEWS, 2014, 40 (09) : 1065 - 1072
  • [39] How to find the Ariadne's thread in the labyrinth of salvage treatment options for metastatic colorectal cancer?
    Bronte, Giuseppe
    Rolfo, Christian
    Peeters, Marc
    Russo, Antonio
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (06) : 743 - 748
  • [40] Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer
    Koizumi, W.
    Boku, N.
    Yamaguchi, K.
    Miyata, Y.
    Sawaki, A.
    Kato, T.
    Toh, Y.
    Hyodo, I.
    Nishina, T.
    Furuhata, T.
    Miyashita, K.
    Okada, Y.
    ANNALS OF ONCOLOGY, 2010, 21 (04) : 766 - 771
12345